Interpersonal behavior and experience of patients with chronic depression or borderline personality disorder: Examining the long-term effectiveness of disorder-specific psychotherapy regarding biological (oxytocin), (epi-)genetic and clinical variables - CBASP-DBT-Study

Klinikum der Universität München, Campus Großhadern0 个研究点目标入组 500 人开始时间: 2020年5月28日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Participation in the DBT-program or in the CBASP program for patients with BPD or CD (according to DSM-5).
•Psychologically and physiologically healthy participants, without any psychiatric illness in the past (participant does not fulfill any diagnosis in the SKID-5-CV and does not fulfill more than three criteria for any of the personality disorders in the SKID-5-PD).

•Patient groups:
•- Acute suicidal ideation
•- Any unstable or not sufficiently treated accompanying somatic disorder (e.g. hypothyroidism orhypertonia), including acute or chronic infections and autoimmune diseases
•- Pregnancy
•Control group:
•- Any unstable or not sufficiently treated concomitant somatic disorders (e.g. hypothyroidism or hypertonia), including acute or chronic infections and autoimmune diseases
•- Previous participation at any study including the cyberball paradigm
•- Current or previous (within the last 10 years) intake of psychiatric drugs (exception: benzodiazepine, z-medication)
•- Pregnancy and breastfeeding period
•- Previous psychiatric treatment
•- Previous psychotherapeutic treatment (within the last 10 years)
•- Excessive smoking (> 1,5 packages/day)
•- Noticeable score on the BDI (> 12) and on the SKID-5-CV/PD-Screenings

发起方

Klinikum der Universität München, Campus Großhadern